India's Emcure Pharmaceuticals aims to raise $400-$500 million from an initial public offering planned for next year, two sources said, reviving listing plans the drugmaker ..
India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an initial public offering, which a source with direct knowledge of the matter said could be worth up to 50 billion rupees ($671.89 million).